CIK 0001460702 · Non-accelerated filer<br>Smaller reporting company
FF EAI Robotics Ecosystem Inc.
Sign in to watch- Ticker
- FFR
- Exchange
- Nasdaq
- Industry
- Finance Services
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 263474527
- Phone
- (760) 918-9165
- Business address
- 1990 E. GRAND AVENUE, EL SEGUNDO, CA, 90245
- Former names
- AIxCrypto Holdings, Inc., Qualigen Therapeutics, Inc., RITTER PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-07-11 | Ritter Ira E. Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2022-07-11 | EMERY SIDNEY W JR Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2022-07-11 | ARSHAD TARIQ SVP/Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +102,000 | 102,000 | ||
| 2022-07-11 | Kruger Kurt H Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2022-07-11 | Abdul-Ahad Wajdi Vice President, R & D, CSO | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2022-07-11 | Lotz Christopher L. Vice President of Finance, CFO | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2022-07-11 | David Richard A. Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2022-07-11 | Poirier Michael S. Chairman and CEO | Grant or award · Stock Option (Right to Buy) | +375,000 | 375,000 | ||
| 2022-07-11 | BROIDRICK AMY S. President/CSO | Grant or award · Stock Option (Right to Buy) | +130,000 | 130,000 | ||
| 2022-07-11 | Korenberg Matthew E Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2022-07-11 | Sinha Shishir K. VP, COO & Secretary | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2022-06-22 | Poirier Michael S. Chairman and CEO | Purchase | +30,000 | $0.57 | $17K | 199,202 |
| 2022-06-14 | BROIDRICK AMY S. President/CSO | Purchase | +30,000 | $0.62 | $19K | 34,500 |
| 2021-12-08 | BROIDRICK AMY S. President/ChiefStrategyOfficer | Grant or award · Stock Option (Right to Buy) | +300,000 | 300,000 | ||
| 2021-12-08 | ARSHAD TARIQ SVP/Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +300,000 | 300,000 | ||
| 2021-08-19 | Kruger Kurt H Director | Purchase | +4,000 | $1.23 | $5K | 14,000 |
| 2021-08-19 | Kruger Kurt H Director | Purchase | +4,000 | $1.22 | $5K | 18,000 |
| 2021-05-17 | ARSHAD TARIQ SVP/Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2021-04-26 | BROIDRICK AMY S. EVP, Chief Strategy Officer | Purchase | +4,500 | $2.03 | $9K | 4,500 |
| 2021-04-20 | Poirier Michael S. Chairman, CEO & President | Purchase | +11,005 | $1.80 | $20K | 11,005 |
Page 1 of 7 · 139 trades